https://www.selleckchem.com/pr....oducts/cirtuvivint.h
PARK2 is a potential tumour suppressor gene and its genetic alterations (regionic loss) are common across many human cancers. The association of PARK2 germline variations (SNPs) with Parkinson's has been shown, but their association in development and progression of cancer remains elusive. The aim of this study was to identify association of PARK2 polymorphisms (rs1801474, rs1801334) with colorectal cancer in a case control study design. This case control study included a total of 650 genetically unrelated subjects comprising 300 co
Like
Comment
Share
